SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
23-Jan-24 8:37 PM View: | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 17,273 | -- | -- | (100%) 17.27K to 0 | |
03-Jan-24 6:16 PM View: | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 6,808 | $58.75 | $399,970.00 | 65% 10.46K to 17.27K | |
24-Jan-23 4:00 PM View: | Mirati Therapeutics, Inc. (MRTX) | 20-Jan-23 | Grant | 4,444 | -- | -- | 74% 6.02K to 10.46K | |
16-Aug-22 4:15 PM View: | Mirati Therapeutics, Inc. (MRTX) | 12-Aug-22 | Option Exercise | 10,000 | $27.00 | $270,000.00 | 166% 6.02K to 16.02K | |
16-Aug-22 4:15 PM View: | Mirati Therapeutics, Inc. (MRTX) | 12-Aug-22 | Option Sale | 10,000 | $85.49 | $854,899.00 | (62%) 16.02K to 6.02K | |
22-Mar-22 5:52 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 21-Mar-22 | Option Exercise | 6,000 | $25.58 | $153,480.00 | 100% 0 to 6.0K | |
22-Mar-22 5:52 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 21-Mar-22 | Planned Option Sale | 6,000 | $67.83 | $406,970.00 | (100%) 6.0K to 0 | |
18-Jan-22 6:21 PM View: | Mirati Therapeutics, Inc. (MRTX) | 14-Jan-22 | Grant | 2,546 | -- | -- | 73% 3.48K to 6.02K | |
06-Apr-21 8:06 PM View: | Mirati Therapeutics, Inc. (MRTX) | 05-Apr-21 | Option Exercise | 2,250 | $6.78 | $15,255.00 | 65% 3.48K to 5.72K | |
06-Apr-21 8:06 PM View: | Mirati Therapeutics, Inc. (MRTX) | 05-Apr-21 | Market Option Sale (Planned) | 2,250 | $177.11 | $398,507.00 | (39%) 5.72K to 3.48K | |
03-Feb-21 5:08 PM View: | Mirati Therapeutics, Inc. (MRTX) | 02-Feb-21 | Option Exercise | 2,250 | $6.78 | $15,255.00 | 65% 3.48K to 5.72K | |
03-Feb-21 5:08 PM View: | Mirati Therapeutics, Inc. (MRTX) | 02-Feb-21 | Market Option Sale (Planned) | 2,250 | $191.12 | $430,018.00 | (39%) 5.72K to 3.48K | |
20-Jan-21 6:17 PM View: | Mirati Therapeutics, Inc. (MRTX) | 15-Jan-21 | Grant | 1,475 | -- | -- | 74% 2.0K to 3.48K | |
16-Dec-20 5:37 PM View: | Mirati Therapeutics, Inc. (MRTX) | 14-Dec-20 | Option Exercise | 2,250 | $6.78 | $15,255.00 | 112% 2.0K to 4.25K | |
16-Dec-20 5:37 PM View: | Mirati Therapeutics, Inc. (MRTX) | 14-Dec-20 | Market Option Sale (Planned) | 2,250 | $246.28 | $554,127.00 | (53%) 4.25K to 2.0K | 5% |
13-Aug-20 4:03 PM View: | Mirati Therapeutics, Inc. (MRTX) | 11-Aug-20 | Option Exercise | 2,250 | $6.78 | $15,255.00 | 112% 2.0K to 4.25K | |
13-Aug-20 4:03 PM View: | Mirati Therapeutics, Inc. (MRTX) | 11-Aug-20 | Market Option Sale (Planned) | 2,250 | $126.41 | $284,428.00 | (53%) 4.25K to 2.0K | (86%) |
20-May-20 5:10 PM View: | Mirati Therapeutics, Inc. (MRTX) | 18-May-20 | Option Exercise | 4,000 | $6.78 | $27,120.00 | 200% 2.0K to 6.0K | |
20-May-20 5:10 PM View: | Mirati Therapeutics, Inc. (MRTX) | 18-May-20 | Market Option Sale | 4,000 | $106.86 | $427,440.00 | (67%) 6.0K to 2.0K | (120%) |
07-Jan-20 8:29 PM View: | Mirati Therapeutics, Inc. (MRTX) | 03-Jan-20 | Grant | 2,000 | -- | -- | 100% 0 to 2.0K | |
22-Nov-19 4:46 PM View: | Mirati Therapeutics, Inc. (MRTX) | 20-Nov-19 | Option Exercise | 3,000 | $6.78 | $20,340.00 | 100% 0 to 3.0K | |
22-Nov-19 4:46 PM View: | Mirati Therapeutics, Inc. (MRTX) | 20-Nov-19 | Market Option Sale (Planned) | 3,000 | $94.74 | $284,220.00 | (100%) 3.0K to 0 | (148%) |
23-Aug-19 6:01 PM View: | Mirati Therapeutics, Inc. (MRTX) | 21-Aug-19 | Option Exercise | 3,000 | $6.78 | $20,340.00 | 100% 0 to 3.0K | |
23-Aug-19 6:01 PM View: | Mirati Therapeutics, Inc. (MRTX) | 21-Aug-19 | Market Option Sale (Planned) | 3,000 | $89.24 | $267,720.00 | (100%) 3.0K to 0 | (163%) |
24-May-19 5:00 PM View: | Mirati Therapeutics, Inc. (MRTX) | 22-May-19 | Option Exercise | 3,000 | $6.78 | $20,340.00 | 100% 0 to 3.0K | |
24-May-19 5:00 PM View: | Mirati Therapeutics, Inc. (MRTX) | 22-May-19 | Market Option Sale (Planned) | 3,000 | $75.20 | $225,597.00 | (100%) 3.0K to 0 | (212%) |
12-Mar-19 4:51 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 11-Mar-19 | Option Exercise | 1,546 | $23.40 | $36,176.40 | 100% 0 to 1.55K | |
12-Mar-19 4:51 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 11-Mar-19 | Market Option Sale (Planned) | 1,546 | $99.16 | $153,301.00 | (100%) 1.55K to 0 | 57% |
22-Feb-19 7:00 PM View: | Mirati Therapeutics, Inc. (MRTX) | 20-Feb-19 | Option Exercise | 3,000 | $6.78 | $20,340.00 | 100% 0 to 3.0K | |
22-Feb-19 7:00 PM View: | Mirati Therapeutics, Inc. (MRTX) | 20-Feb-19 | Market Option Sale (Planned) | 3,000 | $73.64 | $220,921.00 | (100%) 3.0K to 0 | (219%) |
13-Feb-19 8:50 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-19 | Option Exercise | 5,000 | $23.40 | $117,000.00 | 100% 0 to 5.0K | |
13-Feb-19 8:50 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-19 | Market Option Sale (Planned) | 5,000 | $90.00 | $450,000.00 | (100%) 5.0K to 0 | 53% |
13-Feb-19 8:50 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 11-Feb-19 | Option Exercise | 2,734 | $23.40 | $63,975.60 | 100% 0 to 2.73K | |
13-Feb-19 8:50 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 11-Feb-19 | Market Option Sale (Planned) | 2,734 | $90.02 | $246,102.00 | (100%) 2.73K to 0 | 53% |
16-Jun-17 4:58 PM View: | Xencor Inc (XNCR) | 14-Jun-17 | Market Sale | 20,000 | $20.61 | $412,238.00 | (29%) 68.58K to 48.58K | (117%) |
06-Jun-17 6:33 PM View: | Xencor Inc (XNCR) | 02-Jun-17 | Market Sale | 2,366 | $22.00 | $52,052.00 | (3%) 70.94K to 68.58K | (103%) |
31-May-17 9:27 PM View: | Xencor Inc (XNCR) | 26-May-17 | Market Option Sale | 12,400 | $22.19 | $275,213.00 | (15%) 83.34K to 70.94K | (102%) |
31-May-17 9:27 PM View: | Xencor Inc (XNCR) | 24-May-17 | Option Exercise | 76,744 | $0.59 | $45,279.00 | 1163% 6.6K to 83.34K | |
15-Aug-16 7:50 PM View: | Xencor Inc (XNCR) | 15-Aug-16 | Market Option Sale | 3,400 | $22.67 | $77,074.00 | (34%) 10.0K to 6.6K | (83%) |
15-Aug-16 7:50 PM View: | Xencor Inc (XNCR) | 11-Aug-16 | Option Exercise | 10,000 | $0.59 | $5,900.00 | 100% 0 to 10.0K | |
15-Jun-15 6:35 PM View: | Xencor Inc (XNCR) | 15-Jun-15 | Option Exercise | 10,000 | $0.59 | $5,900.00 | 100% 0 to 10.0K | |
15-Jun-15 6:35 PM View: | Xencor Inc (XNCR) | 15-Jun-15 | Market Option Sale | 10,000 | $19.21 | $192,114.00 | (100%) 10.0K to 0 | (116%) |
14-Apr-15 5:12 PM View: | Regulus Therapeutics Inc. (RGLS) | 13-Apr-15 | Option Exercise | 20,000 | $4.78 | $95,600.00 | 100% 0 to 20.0K | |
14-Apr-15 5:12 PM View: | Regulus Therapeutics Inc. (RGLS) | 13-Apr-15 | Market Option Sale | 20,000 | $17.66 | $353,164.00 | (100%) 20.0K to 0 | 99% |
12-Oct-10 1:45 PM View: | ZymoGenetics, Inc. (ZGEN) | 08-Oct-10 | Disposition (change in control) | 468,750 | $9.75 | $4,570,310.00 | (80%) 584.15K to 115.4K | 0% |
23-Aug-10 1:53 PM View: | ZymoGenetics, Inc. (ZGEN) | 19-Aug-10 | Option Exercise | 426,000 | $2.78 | $1,183,300.00 | 269% 158.15K to 584.15K | |
15-May-09 7:56 PM View: | QLT Inc. (NVLNF) | 14-May-09 | Purchase | 20,000 | $2.07 | $41,400.00 | 100% 0 to 20.0K | |
21-Feb-08 1:48 PM View: | ZymoGenetics, Inc. (ZGEN) | 19-Feb-08 | Market Purchase | 11,000 | $9.13 | $100,462.00 | 7% 147.15K to 158.15K | (5%) |
22-Jan-08 6:03 PM View: | ZymoGenetics, Inc. (ZGEN) | 18-Jan-08 | Grant | 100 | -- | -- | < 1% 147.05K to 147.15K | |
07-Aug-07 11:04 AM View: | ZymoGenetics, Inc. (ZGEN) | 03-Aug-07 | Market Purchase | 15,750 | $12.56 | $197,847.00 | 12% 131.3K to 147.05K | (31%) |